Johannes F.E. Mann

4 ta ish

Friedrich-Alexander-University Erlangen-Nürnberg

1. Dapagliflozin in Patients with Chronic Kidney Disease

   Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter +11

   Maqola20205 iqtibos

   ABIABI:AkademIndex/2026.other.282519

2. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

   Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12

   MaqolaOAOchiq kirish20164 iqtibos

   ABIABI:AkademIndex/2026.other.057706

3. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

   Michael Böhm, Helmut Schumacher, Koon Teo +10

   Sharh maqola20173 iqtibos

   ABIABI:AkademIndex/2026.other.295827

4. Chronic Kidney Disease

   Ernesto L. Schiffrin, Mark L. Lipman, Johannes F.E. Mann

   Sharh maqola20073 iqtibos

   ABIABI:AkademIndex/2026.other.535996